Combining thioridazine and loratadine for the treatment of gastrointestinal tumor

In 2015, the American Society of Clinical Oncology announced that strategies of using combination therapies have been indicated to be effective against many types of cancer. In the present study, thioridazine (THZ) was used in a combination therapy with loratadine (LOR) to target gastrointestinal tu...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Tingting, Hu, Yunlong, Liu, Bin, Huang, Xinping, Li, Qin, Gao, Ningning, Jin, Zhenchao, Jia, Tieliu, Guo, Deyin, Jin, Guangyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5649607/
https://www.ncbi.nlm.nih.gov/pubmed/29085455
http://dx.doi.org/10.3892/ol.2017.6815

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5649607/
https://www.ncbi.nlm.nih.gov/pubmed/29085455
http://dx.doi.org/10.3892/ol.2017.6815

Ejemplares similares